JANECIA JACKSON: Open Payments
NPI 1720557671 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 104 payments from 16 companies in 2025. Trend: 2023 $80 · 2024 $531 · 2025 $1,877
Food & beverage: $1,868Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $498 |
| Otsuka America Pharmaceutical, Inc. | 16 | $304 |
| Neurocrine BioSciences, Inc. | 6 | $163 |
| Vanda Pharmaceuticals Inc. | 9 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $140 |
| Teva Pharmaceuticals USA, Inc. | 10 | $138 |
| Janssen Pharmaceuticals, Inc | 4 | $121 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Alkermes, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
Products named: VRAYLAR, REXULTI, INGREZZA, FANAPT, CAPLYTA, Auvelity, UZEDY, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
